Amy Rabourn
Treasurer en OCUPHIRE PHARMA, INC. .
Fortuna: 11 823 $ al 30/04/2024
Perfil
Amy Rabourn is currently the Treasurer & Senior Vice President-Finance at Ocuphire Pharma, Inc. Prior to her current position, she worked as the Finance Director at Gemphire Therapeutics, Inc. from 2014 to 2019.
Ms. Rabourn has an undergraduate and graduate degree from the University of Michigan.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OCUPHIRE PHARMA, INC.
0.03% | 15/04/2024 | 7 702 ( 0.03% ) | 11 823 $ | 30/04/2024 |
Cargos activos de Amy Rabourn
| Empresas | Cargo | Inicio |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Treasurer | - |
Antiguos cargos conocidos de Amy Rabourn.
| Empresas | Cargo | Fin |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Director Financiero/CFO | 01/12/2019 |
Formación de Amy Rabourn.
| University of Michigan | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
- Bolsa de valores
- Insiders
- Amy Rabourn